Cardinal Health (CAH) upgraded at Sterne Agee to Buy from Neutral. $73 price target. Should deliver superior EPS growth relative to the S&P 500.
Endo Health (ENDP) upgraded at Needham to Underperform to Hold, Needham said. Valuation call.
Endo Health upgraded at Cantor to Hold. $54 price target. Company boosted guidance, but appears fully valued.
Must Read: A Future IPO as Exciting as Twitter
Halcon (HK) downgraded at Canaccord from Buy to Hold. Valuation call, based on a $6 price target.
Pioneer Natural Resources (PXD) downgraded at Sterne Agee to Neutral from Buy. Weakening earnings growth outlook.
Red Robin (RRGB) downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Valuation call, based on an $80 price target.
Southern Copper (SCCO)upgraded at Cowen to Market Perform. $30 price target. Company is looking to cut costs.
T-Mobile (TMUS)upgraded at Canaccord to Buy. $33 price target. Company is seeing higher subscriber growth.